Number of Shares
6.30 Mil
Current Holdings Value*
$185.99 Mil
% of Portfolio
3.11%
Total Estimate Gain
$-11.03 Mil
% of Total Estimate Gain
-4.97%

RA CAPITAL MANAGEMENT, L.P.'s Avidity Biosciences Inc Holding Summary

As of 2025-03-31, RA CAPITAL MANAGEMENT, L.P. held 6.30 Mil shares of Avidity Biosciences Inc(RNA), totaling $185.99 Mil. This investment constitutes 3.11% of their stock portfolio, and RA CAPITAL MANAGEMENT, L.P. now holds 5.23% of the outstanding Avidity Biosciences Inc(RNA) stock.

The initial trade took place in 2021Q3. And since then RA CAPITAL MANAGEMENT, L.P. has made 7 purchases of RNA, at an average price of $21.61, for a total of 10.26 Mil shares. In addition, there have been 1 sales at an average price of $6.68 for 3.96 Mil shares. Based on historical transaction data and RNA's current price of $29.25, RA CAPITAL MANAGEMENT, L.P.'s estimated gain on his RNA holdings is $-11.03 Mil, reflecting a -4.97% gain to date.

RA CAPITAL MANAGEMENT, L.P. RNA ($29.25) Holding Chart

RA CAPITAL MANAGEMENT, L.P. RNA ($29.25) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1